Role of Artificial Intelligence in Retinal Diseases

Abstract

Artificial intelligence (AI) has already found its way into ophthalmology, with the first approved algorithms that can be used in clinical routine. Retinal diseases in particular are proving to be an important area of application for AI, as they are the main cause of blindness and the number of patients suffering from retinal diseases is constantly increasing. At the same time, regular imaging using high-resolution modalities in a standardised and reproducible manner generates immense amounts of data that can hardly be processed by human experts. In addition, ophthalmology is constantly experiencing new developments and breakthroughs that require a re-evaluation of patient management in routine clinical practice. AI is able to analyse these volumes of data efficiently and objectively and also provide new insights into disease progression and therapeutic mechanisms by identifying relevant biomarkers. AI can make a significant contribution to screening, classification and prognosis of various retinal diseases and can ultimately be a clinical decision support system, that significantly reduces the burden on both everyday clinical practice and the healthcare system, by making more efficient use of costly and time-consuming resources.

Keywords

retina - optical coherence tomography - artificial intelligence - retinal imaging

Publication History

Received: 24 April 2024

Accepted: 30 July 2024

Article published online:
16 September 2024

• References/Literatur

• 1 Klaver CC, Wolfs RC, Vingerling JR. et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998; 116: 653-658
• 2 Lim JH, Wickremasinghe SS, Xie J. et al. Delay to treatment and visual outcomes in patients treated with anti-vascular endothelial growth factor for age-related macular degeneration. Am J Ophthalmol 2012; 153: 678-686 686.e1–2
• 3 Bressler NM, Doan QV, Varma R. et al. Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration. Arch Ophthal 2011; 129: 709-717
• 4 Johnston RL, Lee AY, Buckle M. et al. UK Age-Related Macular Degeneration Electronic Medical Record System (AMD EMR) Users Group Report IV: Incidence of Blindness and Sight Impairment in Ranibizumab-Treated Patients. Ophthalmology 2016; 123: 2386-2392
• 5 Heier JS, Lad EM, Holz FG. et al. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. Lancet 2023; 402: 1434-1448
• 6 Khanani AM, Patel SS, Staurenghi G. et al. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. Lancet 2023; 402: 1449-1458
• 7 Schmidt-Erfurth U, Klimscha S, Waldstein SM. et al. A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration. Eye (Lond) 2017; 31: 26-44
• 8 Schmidt-Erfurth U, Sadeghipour A, Gerendas BS. et al. Artificial intelligence in retina. Prog Retin Eye Res 2018; 67: 1-29
• 9 LeCun Y, Bengio Y, Hinton G. Deep learning. Nature 2015; 521: 436-444
• 10 Teo ZL, Tham YC, Yu M. et al. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology 2021; 128: 1580-1591
• 11 Abràmoff MD, Lavin PT, Birch M. et al. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit Med 2018; 1: 39
• 12 Bhaskaranand M, Ramachandra C, Bhat S. et al. The Value of Automated Diabetic Retinopathy Screening with the EyeArt System: A Study of More Than 100,000 Consecutive Encounters from People with Diabetes. Diabetes Technol Ther 2019; 21: 635-643
• 13 Lawrence MG. The accuracy of digital-video retinal imaging to screen for diabetic retinopathy: an analysis of two digital-video retinal imaging systems using standard stereoscopic seven-field photography and dilated clinical examination as reference standards. Trans Am Ophthalmol Soc 2004; 102: 321-340
• 14 Flaxel CJ, Adelman RA, Bailey ST. et al. Diabetic Retinopathy Preferred Practice Pattern^® . Ophthalmology 2020; 127: P66-P145
• 15 Gulshan V, Peng L, Coram M. et al. Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. JAMA 2016; 316: 2402-2410
• 16 Ting DSW, Cheung CY, Lim G. et al. Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes. JAMA 2017; 318: 2211-2223
• 17 Gerendas BS, Bogunovic H, Sadeghipour A. et al. Computational image analysis for prognosis determination in DME. Vis Res 2017; 139: 204-210
• 18 Wong WL, Su X, Li X. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2014; 2: e106-e116
• 19 Li JQ, Welchowski T, Schmid M. et al. Prevalence and incidence of age-related macular degeneration in Europe: a systematic review and meta-analysis. Br J Ophthalmol 2020; 104: 1077-1084
• 20 Ferris FL3rd Wilkinson CP, Bird A. et al. Clinical classification of age-related macular degeneration. Ophthalmology 2013; 120: 844-851
• 21 Burlina PM, Joshi N, Pekala M. et al. Automated Grading of Age-Related Macular Degeneration From Color Fundus Images Using Deep Convolutional Neural Networks. JAMA Ophthalmol 2017; 135: 1170-1176
• 22 Venhuizen FG, van Ginneken B, van Asten F. et al. Automated Staging of Age-Related Macular Degeneration Using Optical Coherence Tomography. Invest Ophthalmol Vis Sci 2017; 58: 2318-2328
• 23 Leingang O, Riedl S, Mai J. et al. Automated deep learning-based AMD detection and staging in real-world OCT datasets (PINNACLE study report 5). Sci Rep 2023; 13: 19545
• 24 Schmidt-Erfurth U, Waldstein SM, Klimscha S. et al. Prediction of Individual Disease Conversion in Early AMD Using Artificial Intelligence. Invest Ophthalmol Vis Sci 2018; 59: 3199-3208
• 25 Schmidt-Erfurth U, Vogl WD, Jampol LM. et al. Application of Automated Quantification of Fluid Volumes to Anti-VEGF Therapy of Neovascular Age-Related Macular Degeneration. Ophthalmology 2020; 127: 1211-1219
• 26 Schmidt-Erfurth U, Waldstein SM. A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration. Prog Retin Eye Res 2016; 50: 1-24
• 27 Schmidt-Erfurth U, Reiter GS, Riedl S. et al. AI-based monitoring of retinal fluid in disease activity and under therapy. Prog Retin Eye Res 2022; 86: 100972
• 28 Göbel AP, Fleckenstein M, Schmitz-Valckenberg S. et al. Imaging geographic atrophy in age-related macular degeneration. Ophthalmologica 2011; 226: 182-190
• 29 Mai J, Lachinov D, Riedl S. et al. Clinical validation for automated geographic atrophy monitoring on OCT under complement inhibitory treatment. Sci Rep 2023; 13: 7028
• 30 Schmidt-Erfurth U, Mai J, Reiter GS. et al. Therapeutic effect of pegcetacoplan on retinal pigment epithelium (RPE) and photoreceptor (PR) integrity in geographic atrophy (GA) in the phase III OAKS and DERBY trials. Invest Ophthalmol Vis Sci 2023; 64: 919
• 31 Anegondi N, Gao SS, Steffen V. et al. Deep Learning to Predict Geographic Atrophy Area and Growth Rate from Multimodal Imaging. Ophthalmol Retina 2023; 7: 243-252
• 32 Gigon A, Mosinska A, Montesel A. et al. Personalized Atrophy Risk Mapping in Age-Related Macular Degeneration. Transl Vis Sci Technol 2021; 10: 18
• 33 Mai J, Lachinov D, Reiter GS. et al. Deep Learning-Based Prediction of Individual Geographic Atrophy Progression from a Single Baseline OCT. Ophthalmol Sci 2024; 4: 100466
• 34 Gallardo M, Munk MR, Kurmann T. et al. Machine Learning Can Predict Anti-VEGF Treatment Demand in a Treat-and-Extend Regimen for Patients with Neovascular AMD, DME, and RVO Associated Macular Edema. Ophthalmol Retina 2021; 5: 604-624
• 35 Chandra RS, Ying GS. Evaluation of Multiple Machine Learning Models for Predicting Number of Anti-VEGF Injections in the Comparison of AMD Treatment Trials (CATT). Transl Vis Sci Technol 2023; 12: 18
• 36 Bogunović H, Waldstein SM, Schlegl T. et al. Prediction of Anti-VEGF Treatment Requirements in Neovascular AMD Using a Machine Learning Approach. Invest Ophthalmol Vis Sci 2017; 58: 3240-3248
• 37 Bogunovic H, Waldstein SM, Sadeghipour A. et al. Artificial intelligence to predict optimal retreatment intervals in treat-and-extend (T&E). Invest Ophthalmol Vis Sci 2018; 59: 1620
• 38 Bogunović H, Mares V, Reiter GS. et al. Predicting treat-and-extend outcomes and treatment intervals in neovascular age-related macular degeneration from retinal optical coherence tomography using artificial intelligence. Front Med (Lausanne) 2022; 9: 958469
• 39 Campbell JP, Ataer-Cansizoglu E, Bolon-Canedo V. et al. Expert diagnosis of plus disease in retinopathy of prematurity from computer-based image analysis. JAMA Ophthalmol 2016; 134: 651-657
• 40 Kim SJ, Cho KJ, Oh S. Development of machine learning models for diagnosis of glaucoma. PLoS One 2017; 12: e0177726
• 41 Vogl WD, Waldstein SM, Gerendas BS. et al. Analyzing and Predicting Visual Acuity Outcomes of Anti-VEGF Therapy by a Longitudinal Mixed Effects Model of Imaging and Clinical Data. Invest Ophthalmol Vis Sci 2017; 58: 4173-4181
• 42 Chen TC, Lim WS, Wang VY. et al. Artificial Intelligence-Assisted Early Detection of Retinitis Pigmentosa – the Most Common Inherited Retinal Degeneration. J Digit Imaging 2021; 34: 948-958
• 43 Liu YY, Ishikawa H, Chen M. et al. Computerized macular pathology diagnosis in spectral domain optical coherence tomography scans based on multiscale texture and shape features. Invest Ophthalmol Vis Sci 2011; 52: 8316-8322
• 44 Poplin R, Varadarajan AV, Blumer K. et al. Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning. Nat Biomed Eng 2018; 2: 158-164
• 45 Korot E, Pontikos N, Liu X. et al. Predicting sex from retinal fundus photographs using automated deep learning. Sci Rep 2021; 11: 10286
• 46 Chueh KM, Hsieh YT, Chen HH. et al. Identification of Sex and Age from Macular Optical Coherence Tomography and Feature Analysis Using Deep Learning. Am J Ophthalmol 2022; 235: 221-228
• 47 RetInSight GmbH. RetInSight. 2022/2023. Im Internet (Stand: 02.08.2024): https://retinsight.com/
• 48 RetinAI. RetinAI Discovery. 2022 Im Internet (Stand: 02.08.2024): https://www.retinai.com/products/discovery
• 49 iHealthScreen. iPredict. 2020 Im Internet (Stand: 02.08.2024): https://ihealthscreen.org/
• 50 RetinaLyze System A/S. RetinaLyze^®. 2021. Safe, Fast and Efficient Retinal Investigations with AI and Telemedicine. Im Internet (Stand: 02.08.2024): https://www.retinalyze.com/